Together Pharma Ltd
TGPHF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $39 | $38 | $29 | $30 |
| - Cash | $8 | $8 | $4 | $4 |
| + Debt | $59 | $47 | $55 | $55 |
| Enterprise Value | $90 | $77 | $80 | $81 |
| Revenue | $25 | $25 | $23 | $23 |
| % Growth | 0% | 10.8% | 0% | – |
| Gross Profit | $10 | $10 | $9 | $9 |
| % Margin | 38% | 38% | 38.5% | 38.5% |
| EBITDA | $8 | $8 | $6 | $6 |
| % Margin | 30.2% | 30.2% | 27.2% | 27.2% |
| Net Income | $3 | $3 | -$4 | -$4 |
| % Margin | 12.6% | 12.6% | -19.6% | -19.6% |
| EPS Diluted | 0.25 | 0.25 | -0.51 | -0.51 |
| % Growth | 0% | 149% | 0% | – |
| Operating Cash Flow | $2 | $2 | $4 | $4 |
| Capital Expenditures | -$1 | -$1 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $4 | $4 |